Evaluation of the sedative and cardiovascular effects of intramuscular administration of dexmedetomidine with and without concurrent atropine administration in dogs

Journal of the American Veterinary Medical Association

Volumn 239, Issue 1, 2011, Pages 81-89

  Congdon, Jonathan M ^a   Marquez, Megan ^a   Niyom, Sirirat ^a   Boscan, Pedro ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DEXMEDETOMIDINE; HYPNOTIC SEDATIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; BREATHING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOG; DOG DISEASE; DRUG COMBINATION; DRUG EFFECT; HEART ARRHYTHMIA; HEART OUTPUT; HEART RATE; MALE; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ARRHYTHMIAS, CARDIAC; ATROPINE; BLOOD PRESSURE; BODY TEMPERATURE; CARDIAC OUTPUT; CROSS-OVER STUDIES; DEXMEDETOMIDINE; DOG DISEASES; DOGS; DRUG THERAPY, COMBINATION; HEART RATE; HYPNOTICS AND SEDATIVES; MALE; RESPIRATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 79960028261     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.239.1.81     Document Type: Article

References (34)

1. Kuusela E, Raekallio M, Anttila M, et al. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther 2000;23:15-20.
2. Reves JG, Glass PS, Lubarsky DA, et al. Intravenous nonopioid anesthetics. In: Miller RD, ed. Miller's anesthesia. 6th ed. Philadelphia: Elsevier Churchill-Livingstone, 2005;317-378.
3. Bloor BC, Frankland M, Alper G, et al. Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther 1992;263:690-697.
4. Lemke KA, Tranquilli WJ, Thurmon JC, et al. Hemodynamic effects of atropine and glycopyrrolate in isoflurane-xylazineanesthetized dogs. Vet Surg 1993;22:163-169.
5. Kokkonen UM, Eriksson L. Cardiovascular and allied actions of xylazine and atropine in the unanaesthetized goat. J Vet Pharmacol Ther 1987;10:11-16.
6. Dunkle N, Moise NS, Scarlett-Kranz J, et al. Cardiac performance in cats after administration of xylazine or xylazine and glycopyrrolate: echocardiographic evaluations. Am J Vet Res 1986;47:2212-2216.
7. Alvaides RK, Neto FJ, Aguiar AJ, et al. Sedative and cardiorespiratory effects of acepromazine or atropine given before dexmedetomidine in dogs. Vet Rec 2008;162:852-856.
8. Short CE. Effects of anticholinergic treatment on the cardiac and respiratory systems in dogs sedated with medetomidine. Vet Rec 1991;129:310-313.
9. Singh S, Young SS, McDonell WN, et al. Modification of cardiopulmonary and intestinal motility effects of xylazine with glycopyrrolate in horses. Can J Vet Res 1997;61:99-107.
10. Willegers HM, Prinzen FW, Roekaerts PM. Comparison of the effects of dexmedetomidine and esmolol on myocardial oxygen consumption in dogs. Eur J Anaesthesiol 2004;21:957-966.
11. Pypendop BH, Verstegen JP. Hemodynamic effects of medetomidine in the dog: a dose-titration study. Vet Surg 1998;27:612-622.
12. Pagel PS, Kampine JP, Schmeling WT, et al. Comparison of the systemic and coronary hemodynamic actions of desflurane, isoflurane, halothane, and enflurane in the chronically instrumented dog. Anesthesiology 1991;74:539-551.
13. Muir W, Lerche P, Wiese A, et al. Cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alfaxalone in dogs. Vet Anesth Analg 2008;35:451-462.
14. Chen HC, Sinclair MD, Dyson DH, et al. Comparison of arterial pressure waveform analysis with the lithium dilution technique to monitor cardiac output in anesthetized dogs. Am J Vet Res 2005;66:1430-1436.
15. Chen HC, Sinclair MD, Dyson DH. Use of ephedrine and dopamine in dogs for the management of hypotension in routine clinical cases under isoflurane anesthesia. Vet Anaesth Analg 2005;34:301-311.
16. Miyake Y, Wagner AE, Hellyer PW. Evaluation of hemodynamic measurements, including lithium dilution cardiac output, in anesthetized dogs undergoing ovariohysterectomy. J Am Vet Med Assoc 2005;227:1419-1423.
17. Boscan PB, Pypendop BH, Siao KT, et al. Fluid balance, glomerular filtration rate, and urine output in dogs anesthetized for an orthopedic surgical procedure. Am J Vet Res 2010;71:501-507.
18. Wagner AE, Miyake Y. Cardiac output and other hemodynamic variables in anesthetized dogs undergoing laparotomy because of abdominal neoplasia. J Am Vet Med Assoc 2008;232:547-552.
19. Ko JC, Fox SM, Mandsager RE. Effects of preemptive atropine administration on incidence of medetomidine-induced bradycardia in dogs. J Am Vet Med Assoc 2001;218:52-58.
20. Lawrence CJ, Prinzen FW, de Lange S. The effect of dexmedtomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg 1996;82:544-550.
21. Lawrence CJ, Prinzen FW, de Lange S. Hemodynamic and coronary vascular effects of dexmedetomidine in the anesthetized goat. Acta Anaesthesiol Scand 1997;41:830-836.
22. Alibhai HI, Clarke KW, Lee YH, et al. Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs. Vet Rec 1996;138:11-13.
23. Nathan HJ. Coronary physiology. In: Kaplan JA, ed. Cardiac anesthesia. 3rd ed. Philadelphia: WB Saunders Co, 2003;254-255.
24. Pepper MG, Crawley BC. Rate pressure product. Anaesthesia 1984;39:192-193.
25. White WB. Heart rate and rate pressure product as determinants of cardiovascular risk in patients with hypertension. Am J Hypertension 1999;2:50S-55S.
26. Gross ME, Tranquilli WJ. Use of a-2 adrenergic receptor agonists. J Am Vet Med Assoc 1989;195:378-381.
27. Kersten J, Pagel PS, Tessmer JP, et al. Dexmedetomidine alters the hemodynamic effects of desflurane and isoflurane in chronically instrumented dogs. Anesthesiology 1993;79:1022-1032.
28. Mason DJ, O'Grady M, Wood JP, et al. Assessment of lithium dilution cardiac output as a technique for measurement of cardiac output in dogs. Am J Vet Res 2001;62:1255-1261.
29. Mason DJ, O'Grady M, Woods JP, et al. Comparison of a central and a peripheral (cephalic vein) injection site for the measurement of cardiac output using the lithium-dilution cardiac output technique in anesthetized dogs. Can J Vet Res 2002;66:207-210.
30. Mason DJ, O'Grady M, Woods JP, et al. Effect of background serum lithium concentrations on the accuracy of lithium dilution cardiac output determination in dogs. Am J Vet Res 2002;63:1048-1052.
31. Scheinin H, Karhuvaara S, Olkkola KT, et al. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. Clin Pharmacol Ther 1992;52:537-546.
32. Anttila M, Penttila J, Helminen A, et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 2003;56:691-693.
33. Kanto J, Virtanen R, Iisalo E, et al. Placental transfer and pharmacokinetics of atropine after a single maternal intravenous and intramuscular administration. Acta Anaesthesiol Scand 1981;25:85-88.
34. Bloor BC, Frankland M, Alper G, et al. Hemodynamic and sedative effects of dexmedetomidine in a dog. J Pharmacol Exp Ther 1992;263:690-697.